Management of hyponatremia and volume contraction

Neurocritical Care

Volumn 15, Issue 2, 2011, Pages 354-360

  Rabinstein, Alejandro A ^a   Bruder, Nicolas ^b  

^a MAYO CLINIC   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Conivaptan; Fludrocortisone; Hydrocortisone; Saline; Sodium; Vasopressin

Indexed keywords

ALBUMIN; CORTICOSTEROID; FLUDROCORTISONE; HYDROCORTISONE; MINERALOCORTICOID; PLACEBO; SODIUM CHLORIDE;

ALBUMIN BLOOD LEVEL; ANEURYSM RUPTURE; BLOOD CLOTTING DISORDER; BRAIN ISCHEMIA; BRAIN VASOSPASM; CENTRAL VENOUS PRESSURE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERVOLEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPROTEINEMIA; HYPOVOLEMIA; INTRACRANIAL HYPERTENSION; INTRAVENOUS ADMINISTRATION; LUNG EDEMA; METABOLIC ACIDOSIS; NATRIURESIS; OBSERVATIONAL STUDY; PLASMA VOLUME; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SODIUM BALANCE; SODIUM BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; ACUTE DISEASE; FLUID THERAPY; INTENSIVE CARE; METHODOLOGY;

ACUTE DISEASE; CRITICAL CARE; FLUID THERAPY; HUMANS; HYPONATREMIA; HYPOVOLEMIA; SODIUM CHLORIDE; SUBARACHNOID HEMORRHAGE;

EID: 84855899527     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-011-9585-9     Document Type: Review

References (28)

1. Qureshi AI, Suri MF, Sung GY, et al. Prognostic significance of hyperatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;50:749-55.
2. Audibert G, Steinmann G, de Talancé N, et al. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg. 2009;108:1922-8.
3. Suarez JI, Qureshi AI, Parekh PD, et al. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol. 1999;11:178-84. (Pubitemid 29300295)
4. Okuchi K, Fujioka M, Fujikawa A, et al. Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage. Acta Neurochir (Wien). 1996;138: 951-6.
5. Diringer MN, Wu KC, Verbalis JG, Hanley DF. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol. 1992;31:543-50.
6. Rabinstein AA, Wijdicks EF. Hyponatremia in critically ill neurological patients. Neurologist. 2003;9:290-300. (Pubitemid 37484848)
7. Palmer BF. Hyponatraemia in a neurosurgical patient: Syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant. 2000;15:262-8. (Pubitemid 30064288)
8. Brimioulle S, Orellana-Jimenez C, Aminian A, Vincent JL. Hyponatremia in neurological patients: Cerebral salt wasting versus inappropriate antidiuretic hormone secretion. Intensive Care Med. 2008;34:125-31.
9. Diringer MN. Neuroendocrine regulation of sodium and volume following subarachnoid hemorrhage. Clin Neuropharmacol. 1995;18:114-26.
10. Bruder N, Ichai C, Gelb AW. Hyponatremia and subarachnoid hemorrhage: Will that be one pinch or two of salt? Anesth Analg. 2009;108:1734-5.
11. Wijdicks EF, Vermeulen M, Hijdra A, van Gijn J. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: Is fluid restriction harmful? Ann Neurol. 1985;17: 137-40. (Pubitemid 15170433)
12. Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol. 1985;18:211-6. (Pubitemid 15004892)
13. Zeynalov E, Chen CH, Froehner SC, Adams ME, Ottersen OP, Amiry-Moghaddam M, Bhardwaj A. The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema. Crit Care Med. 2008;36:2634-40.
14. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617-23.
15. Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 1990;27:106-8. (Pubitemid 20031367)
16. Zheng B, Qiu Y, Jin H, Wang L, Chen X, Shi C, Zhao S. A predictive value of hyponatremia for poor outcome and cerebral infarction in high-grade aneurysmal subarachnoid haemorrhage patients. J Neurol Neurosurg Psychiatry. 2011;82:213-7.
17. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
18. Wijdicks EF, Vermeulen M, van Brummelen P, van Gijn J. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 1988;90:209-14.
19. Hasan D, Lindsay KW, Wijdicks EF, et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 1989;20:1156-61. (Pubitemid 19226908)
20. Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 1999;91:947-52.
21. Moro N, Katayama Y, Kojima J, Mori T, Kawamata T. Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke. 2003;34:2807-11. (Pubitemid 37517746)
22. Katayama Y, Haraoka J, Hirabayashi H, et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38: 2373-5. (Pubitemid 47457586)
23. Suarez JI, Shannon L, Zaidat OO, et al. Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage. J Neurosurg. 2004;100:585-90. (Pubitemid 38372836)
24. Mayer SA, Solomon RA, Fink ME, et al. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery. 1998;42:759-67.
25. Bhardwaj A. Neurological impact of vasopressin dysregulation and hyponatremia. Ann Neurol. 2006;59:229-36. (Pubitemid 43202475)
26. Rabinstein AA. Vasopressin antagonism: Potential impact on neurologic disease. Clin Neuropharmacol. 2006;29:87-93. (Pubitemid 44357158)
27. Froelich M, Ni Q, Wess C, Ougorets I, Härtl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37:1433-41.
28. Woo CH, Rao VA, Sheridan W, Flint AC. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia. Neurocrit Care. 2009;11:228-34.